Summary: The global market for microneedles was valued at $REDACTED billion in 2023. This market is anticipated to reach $REDACTED billion by the end of 2028, growing at a CAGR of REDACTED% from 2023 through 2028. The growth of the global market is attributed to factors such as the wide range of existing and potential microneedle applications, the increasing demand for dermatology procedures and minimally invasive drug delivery, and the growing number of infectious diseases. The microneedle market is segmented into solid, hollow, coated, dissolving, and hydrogel types. The dissolving microneedle segment is expected to have the highest growth rate. The high growth rate of this segment is attributed to dissolving microneedles’ low cost and better outcomes in a range of applications, from dermatology to disease diagnosis and treatment. Based on application, the market is segmented into disease treatment, immunobiological administration, disease diagnosis, and dermatology applications. The dermatology segment dominates the market. This can be attributed to the cost-effectiveness of microneedling compared to other treatment modalities in dermatology. Some key players in this market include Becton, Dickinson, and Co. (BD); Cynosure; Candela Medical; Cutera Inc.; and LTS Lohmann Therapie-Systeme AG. Report Scope: The current report provides detailed information about the microneedle market. It highlights the current and future market potential for microneedles and provides a detailed analysis of the drivers, restraints, challenges, and opportunities in the market. The report also covers market projections for 2028 and includes the market rankings of key market players. It also covers the competitive environment and regulatory scenario. The report details the market share of microneedles based on product and application. Based on product, the market is segmented into solid microneedles, hollow microneedles, coated microneedles, dissolving microneedles, and hydrogel microneedles. Based on application, the market is segmented into disease treatment, immunobiological administration, disease diagnosis, and dermatology applications. Hydrogel and disease diagnosis applications that are covered in the report are not commercially approved and are being used primarily by research organizations. The market has been divided by geography into North America, Europe, Asia-Pacific, and the Rest of the World. The North American region comprises countries such as the U.S. and Canada; Europe includes Germany, the U.K., Italy, France, Spain, and the Rest of Europe; and Asia-Pacific includes China, India, Japan, South Korea, and the Rest of Asia-Pacific. For market estimates, data has been provided for 2020 and 2021 as the historical years and for 2022 as the base year, with forecasts for 2028. Report Includes: - 30 data tables and 37 additional tables - An overview of the global market for microneedles - Analysis of the global market trends, featuring historical revenue data for 2020 to 2022, estimated figures for 2023, as well as forecasts for 2028, including projections of compound annual growth rates (CAGRs) through 2028 - Evaluation of the current market size and revenue growth prospects, accompanied by a market share analysis by type, application and geographical region - A look at the key market dynamics, the industry structure, regulatory landscape, current outlook and an analysis of the COVID-19 impact on the market for medical devices and microneedles - Discussion of the properties of the latest generation of smart microneedles, such as skin adhesion, dissolvability, responsiveness and tip-substrate detachability, as well as whether they are bionic, bioderived or biocompatible in nature - Review of patents on microneedle array technologies by assignee and products in the pipeline - Coverage of evolving technologies, ESG trends and clinical trials - Competitive benchmarking of key players, categorized by dermatology and vaccine and drug delivery, and their growth strategies - Profiles of leading market participants